The onco pharma franchise in India is one of today’s renowned industries that is emerging as a highly profitable and socially important business opportunity. This is significantly influenced by India’s growing cancer burden. According to the Indian Council of Medical Research (ICMR), India reports 14-15 lakh new cancer cases each year. Even by 2030, cancer cases in India are projected to increase by more than 12%. This worrying trend increases the demand for accessible and affordable oncology treatments, particularly in tier II and III cities. Moreover, there is a high need for affordable oncology medications, which means the majority of the Indian population cannot afford branded cancer medications. This industry is trending toward cost-effective, high-quality generic and branded-generic oncology medicines, making PCD franchises an attractive option.
In addition, government support and health insurance expansion have proven that Ayushman Bharat and state-level health insurance policies now cover oncology treatments. This particularly improves access to pharmaceuticals. However, as hospitals and private clinics seek reputable pharmaceutical partners, the demand for GMP/WHO-certified oncology medications will increase. Beyond these, the Indian oncology market is expected to reach USD 1.5-2 billion by 2026, with an 8-10% CAGR. In this oral chemotherapy, targeted therapy, and biosimilars are receiving substantial interest. As a result, there is a huge market scope and benefits of the onco PCD pharma franchise in India.
The important steps to invest in the Best Onco Pharma Franchise in India.
Here’s a detailed, easy-to-follow guide to selecting the best Onco PCD franchise in India—ideal for budding entrepreneurs wishing to enter the oncology industry with confidence:
- Understand the oncology market demand: first, you need to examine the current demand for cancer medicines in India. Then you should concentrate on the most prevalent categories, such as breast cancer, lung cancer, blood cancer, and prostate cancer. Also, you have to consider whether the company offers targeted medicines, chemotherapy, immunotherapy, etc.
- Check the company’s product portfolio: a reputable onco pharma franchise company should provide a comprehensive selection of cancer medications. This includes tablets, capsules, injections, vials, and lyophilized powders, and also products that span cytotoxics, hormone treatment, and biologics. Also, you should search for WHO-GMP-certified manufacturing facilities and DCGI-approved formulas.
- Verify certifications and quality standards: ensure the company has qualifications such as WHO-GMP compliance, ISO 9001:2015, FSSAI and DCGI licenses. However, quality assurance is crucial in oncology since the medications are both high-risk and life-saving.
- Evaluate monopoly rights and franchise terms: choose a renewed onco PCD pharma franchise in India that has unambiguous monopoly rights in your target territory. Also, you need to check the terms associated with the minimum purchase order, return policies and area-based exclusivity.
- Evaluate marketing and promotional support: a solid ONCO PCD franchise business company should offer visual aids, MR packs and product brochures, doctor’s samples, reminder notes, and gift items. In this, there is a huge role for digital support (e-detail, PDFS, WhatsApp marketing).
- Inquire about logistics and delivery timelines: Prompt delivery of oncology products is crucial. Also, ask about delivery timelines, inventory availability and also courier partnerships and cold-chain support (for temperature-sensitive items).
- Read reviews and speak with existing franchise partners: check out internet reviews, testimonials, and LinkedIn feedback. Moreover, speak with current or past franchisees to learn about product efficacy, profitable margins, and support after onboarding.
- Compare pricing and margins: ensure that the company has competitive pricing and profit margins. Also, you need to understand the price-to-market fit and figure out your net margins after freight, GST, and discounts.
- Get everything in writing: before signing, be sure to request the franchise agreement. You can also check for clarity in the product supply commitment, monopoly area, and payment terms. Also, you have to consider any legal requirements or liabilities.
Spica Drugs offered various types of the onco medicines.
- Chemotherapy drugs can be used to kill or slow the growth of rapidly dividing cancer cells, thereby treating cancer. For example, breast, lung, ovarian, leukemia, lymphoma, and colon cancers. Furthermore, these are utilized before (neoadjuvant) or after (adjuvant) surgery to shrink tumors or kill any remaining cancer cells.
- Targeted therapy: This treatment targets certain genes or proteins in cancer cells. This also cures her2-positive breast cancer, chronic myeloid leukemia, and non-small cell lung cancer. In addition, there are less negative effects than chemotherapy.
- Immunotherapy allows the patient’s immune system to recognize and remove cancer cells. This is also helpful against melanoma, lung cancer, bladder cancer, and certain head and neck cancers. This includes checkpoint inhibitors and CAR-T cell therapies.
- Hormone therapy: This involves blocking or lowering hormone levels to keep hormone-sensitive cancers from spreading. It is particularly effective in breast cancer (estrogen-driven) and prostate cancer (testosterone-driven). We have included drugs such as tamoxifen, letrozole, and leuprolide.
- Biosimilars and biologics: Genetically created proteins are used to treat cancer by mimicking naturally occurring substances in the body. This medication is commonly used to treat leukemia, lymphoma, and colorectal cancer. For example, consider bevacizumab with rituximab.
Finalization
To finalize this whole discussion, we tell you that the onco pharma franchise in India is today’s most demanded business model in the pharma sector. Moreover, Spica Drugs is a well-known name in this sector. Hence, to get the franchisee benefits for the onco medicines products, you should join us now.
Contact Details
Name: Spica Drugs
Ph: +91-8949055013 , 0172-5020013
Email: info@janusbiotech.in